Faculty
Wu, Chun-Ying / 吳俊穎
Institute of Biomedical Informatics
02-2826-7000#67155
02-2820-2508
cywu4@nycu.edu.tw
Current Position
Associate Dean and Chair Professor, College of Medicine, National Yang Ming Chiao Tung University
Director, Professor, Institute of Biomedical Informatics, National Yang Ming Chiao Tung University
Chief, Division of Translational Research, Taipei Veterans General Hospital
Professor, Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital
Office
R327-1, 3F, Shou-Ren Building
Academic Degrees
M.D., Ph.D., National Taiwan University, Taiwan
M.P.H., Quantitative Method, and LL.M., Health Law, Harvard University
Representative honors
NSTC, Outstanding Research Awards, 2015 and 2021
The Best 9 Article of NYMU, 2020
Medical Model Award, 2018
National Innovation Award, 2016
Outstanding Research Award, 2015
Asia Pacific Emerging Leadership Lecturer, 2015
Best Teaching Lectureship Glass Award, NYMU, 2013
Advances in Digestive Medicine (Editor-in-Chief)
Journal of Gastroenterology & Hepatology (Associate Editor)
Gut (Editor)
Research Interests
Health Big Data Research and meta-analysis
Digestive Cancer Translational Research
Gut Microbiota Research
Empirical Legal Research and biotechnology regulation
Selected Publications
-
Lee TY, Hsu YC, Tseng HC, Yu SH, Lin JT, Wu MS, Wu CY*. Association of daily aspirin therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B.
JAMA Intern Med 2019 May 1; 179(5): 633-40 (SCI, IF 44.409, 7/172)
-
Yeo YH, Ho HJ, Yang HI…, Wu CY*, Nguyen MH. The HBsAg seroclearance rate and predictors in adults with chronic hepatitis B: a systematic review and meta-analysis.
Gastroenterology 2019 Feb; 156(3): 635-46 (SCI, IF 33.883, 3/93)
-
Yeo YH, Shiu SI, Ho HJ, Zou B, Lin JT, Wu MS, Liou JM, Wu CY*. First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis.
Gut 2018 Jan; 67(1): 20-7 (SCI, IF 31.793, 4/93)
-
Wu CY*, Ho HJ, Wu CY, Chen YJ, Lee TY, Hsu YC, Lin JT. Association between proton pump inhibitor use and mortality in hepatocellular carcinoma patients receiving tyrosine kinase inhibitor. Gut 2021 Sep 9; gutjnl-2020-321932 (online ahead of print) (SCI, IF 31.793, 4/93)
-
Hsu YC, Yip TCF, Ho HJ, Wong VWS, Huang YT, El-Serag HB, Lee TY, Wu MS, Lin JT, Wong GLH, Wu CY*. Predicting hepatocellular carcinoma with population-wide data in previously untreated Asians on antivirals for chronic hepatitis B.
J Hepatol 2018 Aug; 69(2): 278-85 (SCI, IF 30.083, 5/93)
Research Interests
JAMA Intern Med 2019 May 1; 179(5): 633-40 (SCI, IF 44.409, 7/172)
Gastroenterology 2019 Feb; 156(3): 635-46 (SCI, IF 33.883, 3/93)
Gut 2018 Jan; 67(1): 20-7 (SCI, IF 31.793, 4/93)
J Hepatol 2018 Aug; 69(2): 278-85 (SCI, IF 30.083, 5/93)